MA-BRIGHTCOVE/SUNN-STRM
16.7.2024 15:01:59 CEST | Business Wire | Press release
Brightcove (NASDAQ: BCOV), the world’s most trusted streaming technology company, today announced it has added Sunn Stream – a streaming service offering family-friendly movies, music and educational content – to its roster of media customers. Sunn Stream will rely on Brightcove’s two-time Emmy-award-winning platform to distribute its content to audiences nationwide.
Sunn Stream, currently in soft launch, is a streaming service that provides subscribers with personalized, family-friendly content, including movies, music, episodic shows, and educational videos on various topics. Using Brightcove’s reliable and scalable video technology, Sunn Stream will provide its audience with a seamless, curated, user-friendly experience across all devices.
“The streaming industry has clearly become more competitive, with providers striving to capture the attention and loyalty of more discerning audiences,” said Brightcove CEO Marc DeBevoise. “With this evolution, Sunn Stream has realized that it is essential to combine its unique content proposition targeted at a clearly-defined audience with the highest-quality video streaming and an intuitive, personalized user experience. Using our market-leading technology platform, Sunn Stream will be at the forefront of providing their customers with reliable, customized entertainment options, and will have access to best-in-class analytics to track performance.”
The popularity of independent media companies has continued to surge. As more consumers enter the fold, these entities increasingly require partners that can scale with them and ensure that customer experience remains a top priority. Sunn Stream tapped Brightcove’s industry-leading video-cloud streaming platform for its unique advantages, including unparalleled video quality, global scalability, unmatched customer support, and robust analytics.
“We’ve completely updated our Sunn Stream streaming service and app to make them easier to use so more customers can enjoy our films and shows,” said Sunn Stream Founder and President Garrett Z. Sutton. “Our curators will now handpick unexpected recommendations that our customers will love. And we’re more focused on creating an experience for the whole family that brings people together with laughter, tears, and thought-provoking moments.”
Sunn Stream joins a roster of media companies that rely on Brightcove to power their streaming capabilities, including FrightPix, The Academy of Motion Picture Arts and Sciences, Acun Medya, AMC Networks, BBC Studios, Canela Media, J.COM, MotoAmerica, REELZ, SBT TV, and SKY Mexico.
For more information, visit Brightcove.com.
About Sunn Stream
Sunn Stream is more than a streaming platform — it’s an Uncharted Entertainment and Educational Journey that takes users to bold, new worlds of cinema and television with family-friendly online content (movies, music and more) and a new Sunn Stream Film Festival (Coming Soon in 2025). As a modern-day storytelling campfire, it unites people through laughter, tears, and thought-provoking moments. This user-friendly platform delivers new narratives and experiences that appeal to multiple generations. Each month, Sunn Stream’s content curators handpick a collection of unexpected tales that ignite wonder, invite conversations and bridge hearts and minds. In addition to films and exclusive documentaries, this online platform offers quality educational content to fill voids left by public institutions such as financial education. Sunn Stream Members/ Subscribers will have unlimited access to new content that can ignite discussions with friends and family. Founded in 2022, Sunn Stream Founder/President, Bestselling Author and Entrepreneur Garrett Z. Sutton is dedicated to entertaining, educating and expanding horizons for users with new content that enhances lives. And Sunn Stream’s unique platform can be experienced online via SunnStream.com, Sunn Stream Productions App (iOS for iPads and iPhones, Apps for Android) and through Roku, Chromecast, and/or Apple TV devices. And when the credits roll, the journey is just beginning: https://sunnstream.com.
About Brightcove Inc.
Brightcove creates the world’s most reliable, scalable, and secure streaming technology solutions to build a greater connection between companies and their audiences, no matter where they are or on which devices they consume content. In more than 60 countries, Brightcove’s intelligent video platform enables businesses to sell to customers more effectively, media leaders to stream and monetize content more reliably, and every organization to communicate with team members more powerfully. With two Technology and Engineering Emmy® Awards for innovation, uptime that consistently leads the industry, and unmatched scalability, we continuously push the boundaries of what video can do. Follow Brightcove on LinkedIn, X, Facebook, Instagram, Threads, and YouTube. Visit Brightcove.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240716111027/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release
Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize
Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 08:00:00 CEST | Press release
Employee-led recognition places Boomi among the UK's top medium-sized employers, with a flight risk of just 3% against a technology sector average of 42% Boomi achieves an average employee happiness score of 86%, rated Excellent across all six dimensions of WorkL's workplace framework Flight risk of just 3%, compared to a technology sector average of 42%, reflecting exceptional levels of employee loyalty Rated Excellent for Diversity and Inclusion and Confidence in Management Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.b
LTM Has Issued an Offer to Acquire Randstad’s Technology and Consulting Services Business in Europe and Australia to Scale Domain-Driven Solutions and AI Services22.5.2026 07:09:00 CEST | Press release
The deal would be part of a 360° partnership with Randstad involving: Proposed acquisition of USD 500M+ (€469M) business, primarily across Aerospace & Defence, Automotive, Utilities and BFS Five-year IT services partnership to drive AI-enabled transformation for Randstad’s India Global Capability Center Strategic talent MSP to support LTM’s expanding global workforce LTM and Randstad announced that LTM has issued an offer to acquire Randstad’s Technology and Consulting Servicesbusiness in France, Germany, Belgium, Luxembourg and Australia, representing USD 500+ million (€469M) in annual revenue, to scale domain-driven solutions and AI services in the region. The proposed acquisition would expand LTM’s presence in key markets, primarily across Aerospace & Defence, Automotive, Utilities and BFS. It would enable local domain expertise and complementary regional capabilities in domain-driven digital engineering, cybersecurity and IoT, supported by onshore and nearshore delivery through cen
Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases22.5.2026 07:00:00 CEST | Press release
Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will obtain exclusive rights to commercialize a biosimilar for autoimmune diseases across Latin America (LATAM), excluding Brazil. Polpharma Biologics will retain full responsibility for the development and manufacturing of the biosimilar. Tuteur will be responsible for commercialization, marketing, and distribution in the licensed territories. This collaboration reflects a shared commitment to expanding patient access to high-quality, affordable biological therapies across the region. “Partnering with Tuteur represents an important step in advancing our mission to broaden access to biosimilars globally,” said Anjan Selz, CEO of Polpharma Biologics. “With their strong regional expertise and commercial capabilities in LATAM, we are well
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
